Society to Educate Policymakers about Combating Diabetes Epidemic

The Endocrine Society is hosting a Congressional briefing on November 4 to examine policies to help the 29 million Americans who have diabetes and the 86 million who are likely to develop the disease.

A diabetes diagnosis affects an individual’s overall health and quality of life, and the condition is costly to treat. The nation’s total diabetes spending on medical expenditures and lost productivity has soared to $322 billion in 2012, a 48 percent increase over the course of five years.

Millions of people who have diabetes and prediabetes aren’t aware they have the disease. Better preventive care is needed to identify those who are affected before the condition worsens or they develop costly complications. Sustained funding for the National Diabetes Prevention Program and passage of the Medicare Diabetes Prevention Act, which provides Medicare coverage for the program, would help people reduce their risk through a lifestyle intervention program that includes learning about choosing healthier foods and increasing physical activity.

Technologies such as the continuous glucose monitoring (CGM) devices are available to help people with diabetes manage their blood sugar levels. Medicare currently doesn’t cover the technology, so many people who have successfully been using the technology for years must pay out of pocket for it once they turn 65. Since CGM devices also are a building block for the artificial pancreas – a device being developed to automatically manage glucose levels and improve quality of life for people with diabetes – providing insurance coverage needs to be a priority.

The Society is holding the event in conjunction with Diabetes Awareness Month. At the November 4 briefing, leading diabetes experts and advocates will discuss policies and legislation to support diabetes management and preventive care.

What:
Diabetes in America: What Policymakers Should Know
Congressional briefing hosted by the Endocrine Society

Who:
Edward Damiano, PhD
Principal Investigator, Bionic Pancreas
Professor, Biomedical Engineering, Boston University

Nicole Johnson, DrPH, MPH, MA
Miss America 1999
Diabetes patient advocate

Ann Albright, PhD, RD
Director, Division of Diabetes Translation, Centers for Disease Control and Prevention

Linda Siminerio, RN, PhD, CDE
Chair, National Diabetes Education Program
Executive Director, University of Pittsburgh Diabetes Institute

Date:
Wednesday, November 4, 2015
3-4 PM ET

Where:
2322 Rayburn House Office Building

RSVP to Aaron Lohr at [email protected]. Healthy snacks will be provided.

You may also like

  • August 2024 Endocrine Society Advocacy Update

    Revised Version of TROA Passes House Ways & Means Committee On June 27, 2024, the House Ways and Means Committee passed a revised version of the Treat and Reduce Obesity Act (TROA), legislation that would allow Medicare coverage of anti-obesity medications (AOMs), which currently is prohibited under law. The version that passed would only allow…

  • Endocrine Society Continues Global EDC Advocacy; EU Election Results Leaves Outcomes for EDC Legislation Uncertain  

    On June 17, the Endocrine Society joined delegations from dozens of countries gathered in Geneva, Switzerland, for the third session of an ad hoc open-ended working group (OEWG) convened under the United Nations Environment Programme (UNEP) to develop proposals to establish a new science policy panel charged with helping to inform governments, companies, farmers and…

Find more in